Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 5

Zeitschriftenartikel

Schindler, Florian ORCID logoORCID: https://orcid.org/0000-0003-4512-4114; Schinkoethe, Timo; Mahner, Sven ORCID logoORCID: https://orcid.org/0000-0002-2224-5709; Kolben, Thomas; Wuerstlein, Rachel; Culmsee, Carsten; Harbeck, Nadia ORCID logoORCID: https://orcid.org/0000-0002-9744-7372 und Eggersmann, Tanja K. (2023): Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers. In: Therapeutic Advances in Drug Safety, Bd. 14 [PDF, 355kB]

Fey, Theres; Erickson, Nicole ORCID logoORCID: https://orcid.org/0000-0002-0473-7689; Stahler, Arndt; Muenchhoff, Maximilian; Keppler, Oliver T.; Rühlmann, Katharina; Krauss-Pfeiffer, Gabriele; Steinberg, Hannah; Graf, Alexander; Krebs, Stefan; Blum, Helmut; Khatamzas, Elham; Seynstahl, Sarah; Casuscelli, Jozefina; Markwardt, Daniel; Forstpointner, Roswitha; Schinkoethe, Timo; Bergwelt-Baildon, Michael von und Heinemann, Volker (2022): Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV. In: Medical Oncology, Bd. 39, Nr. 6 [PDF, 678kB]

Bitto, Franz-Ferdinand; König, Alexander; Phan-Brehm, Thuy; Vallbracht, Thomas; Koch, Julian Gregor; Schinkoethe, Timo; Wolfgarten, Matthias; Mahner, Sven; Harbeck, Nadia und Würstlein, Rachel (2020): EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients. In: Breast Care, Bd. 15, Nr. 2: S. 171-177

Schinkoethe, Timo (2019): Individualized eHealth Support for Oncological Therapy Management. In: Breast Care, Bd. 14, Nr. 3: S. 130-134

Hofmann, Daniel; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E.; Schinkoethe, Timo; Staib, Peter und Harbeck, Nadia (2013): WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial. In: Trials 14:261 [PDF, 1MB]

Diese Liste wurde am Sat Apr 20 22:12:25 2024 CEST erstellt.